Keep stoploss above Rs 106 in IDFC: Amit Gupta

Published on Mon, Jan 09, 2012 at 14:18 |  Source : CNBC-TV18

Updated at Mon, Jan 09, 2012 at 14:39  

49909 Investors following IDFC. Share this News with them.
0
0
Share on Tumblr
Amit Gupta, Head-Derivatives, ICICI Direct

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Keep stoploss above Rs 106 in IDFC , says Amit Gupta, Head-Derivatives, ICICI Direct.

Gupta told CNBC-TV18, "I spoke about IDFC after the consolidation of August till November and which was taken out in the month of December. We saw that from there on there was very heavy short build up around Rs 105 which dragged the stock towards Rs 90, again it has moved up. But I have seen that 100 call options again are getting shorted. So I have taken this position where we are going short again around Rs 100-102 levels and we are keeping the stop above Rs 106 and we are looking for a target of Rs 90 again."

He further added, "If you look at this particular space where IDFC is, the NBFC, we have seen that very heavy short positions have been rolled from the previous series to the current series. In fact the double amount of positions have been rolled, the same is happening with HDFC and LIC Housing Finance. Both are nearing the very stiff resistance levels. So I fear that the NBFC space may possibly under perform now and IDFC which is already weaker I think it may become more weaker."

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!